Pravastatin sodium
Lipid-regulating drugs | Cardiovascular System
Items (National)
2.1M
NHS Cost
£3.3M
Practices
6,539
Avg per Practice
325
Overview
Pravastatin sodium is prescribed by 6,539 GP practices across England. In the last 12 months, 2,123,487 items were prescribed at a total cost of £3,281,505 to the NHS. It is classified under BNF Chapter Cardiovascular System, Section Lipid-regulating drugs.
Monthly Prescribing Trend
Jun 2026
185,117
Jun 2026
171,377
Jun 2026
185,488
Jun 2026
179,811
Jun 2026
172,697
Jun 2026
182,324
Jun 2026
173,753
Jun 2026
178,526
Jun 2026
179,596
Jun 2026
160,338
Jun 2026
168,959
Jun 2026
170,177
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 87.3K | 167 | 523 | +61.1% ▲ |
| NE | 68.0K | 138 | 493 | +51.7% ▲ |
| PE | 66.4K | 91 | 730 | +124.8% ▲ |
| B | 59.6K | 251 | 237 | -26.9% ▼ |
| NR | 46.6K | 73 | 638 | +96.5% ▲ |
| M | 46.2K | 172 | 268 | -17.4% ▼ |
| NG | 45.6K | 135 | 338 | +4.1% ▲ |
| CM | 44.4K | 66 | 672 | +107.1% ▲ |
| CV | 42.5K | 108 | 394 | +21.3% ▲ |
| DN | 42.3K | 87 | 486 | +49.7% ▲ |
| SK | 40.1K | 72 | 557 | +71.6% ▲ |
| LE | 36.6K | 121 | 303 | -6.8% ▼ |
| IP | 35.5K | 60 | 591 | +82.0% ▲ |
| L | 35.0K | 142 | 246 | -24.1% ▼ |
| TS | 33.4K | 72 | 463 | +42.7% ▲ |
| NN | 32.5K | 65 | 500 | +53.9% ▲ |
| YO | 31.5K | 47 | 671 | +106.6% ▲ |
| BN | 31.4K | 74 | 424 | +30.5% ▲ |
| DE | 29.4K | 80 | 367 | +13.1% ▲ |
| BB | 28.9K | 67 | 431 | +32.8% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| MUNRO MEDICAL CENTRE | 6,238 |
| MODALITY PARTNERSHIP (AWC) | 3,774 |
| VALENS MEDICAL PARTNERSHIP | 3,663 |
BNF Classification
- Chapter: Cardiovascular System
- Section: Lipid-regulating drugs
- Paragraph: Lipid-regulating drugs
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.